NASDAQ:PLUR - Nasdaq - US72942G2030 - Common Stock - Currency: USD
5.3
+0.88 (+19.91%)
The current stock price of PLUR is 5.3 USD. In the past month the price increased by 16.48%. In the past year, price decreased by -8.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 18.05 | 327.47B | ||
AMGN | AMGEN INC | 13.5 | 150.75B | ||
GILD | GILEAD SCIENCES INC | 13.69 | 131.77B | ||
VRTX | VERTEX PHARMACEUTICALS INC | N/A | 114.49B | ||
REGN | REGENERON PHARMACEUTICALS | 11.74 | 56.18B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 41.98B | ||
ARGX | ARGENX SE - ADR | 97.48 | 34.23B | ||
ONC | BEONE MEDICINES LTD-ADR | 6.83 | 28.90B | ||
BNTX | BIONTECH SE-ADR | N/A | 25.19B | ||
NTRA | NATERA INC | N/A | 22.42B | ||
INSM | INSMED INC | N/A | 19.10B | ||
BIIB | BIOGEN INC | 8.05 | 18.65B |
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. The firm is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The firm has a portfolio of over 140 granted patents in approximately 52 countries.
PLURI INC
Matam Park Building 5
Haifa IL
Employees: 112
Phone: 972747108600
The current stock price of PLUR is 5.3 USD. The price increased by 19.91% in the last trading session.
The exchange symbol of PLURI INC is PLUR and it is listed on the Nasdaq exchange.
PLUR stock is listed on the Nasdaq exchange.
7 analysts have analysed PLUR and the average price target is 12.24 USD. This implies a price increase of 130.94% is expected in the next year compared to the current price of 5.3. Check the PLURI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PLURI INC (PLUR) has a market capitalization of 41.50M USD. This makes PLUR a Nano Cap stock.
PLURI INC (PLUR) currently has 112 employees.
PLURI INC (PLUR) has a support level at 4.7 and a resistance level at 5.48. Check the full technical report for a detailed analysis of PLUR support and resistance levels.
The Revenue of PLURI INC (PLUR) is expected to grow by 472.39% in the next year. Check the estimates tab for more information on the PLUR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PLUR does not pay a dividend.
PLURI INC (PLUR) will report earnings on 2025-09-16, after the market close.
PLURI INC (PLUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.61).
The outstanding short interest for PLURI INC (PLUR) is 0.7% of its float. Check the ownership tab for more information on the PLUR short interest.
ChartMill assigns a technical rating of 5 / 10 to PLUR. When comparing the yearly performance of all stocks, PLUR turns out to be only a medium performer in the overall market: it outperformed 59.4% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to PLUR. PLUR may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months PLUR reported a non-GAAP Earnings per Share(EPS) of -3.61. The EPS increased by 14.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -55.37% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to PLUR. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -156.25% and a revenue growth 472.39% for PLUR